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Introduction: Oral cancer is a public health problem worldwide, being tobacco and alcohol
consumption their main risk factors. Sulfotransferase (SULT) 1A1 (encoded by SULT1A1)
is involved in procarcinogens metabolism, such as polycyclic aromatic hydrocarbons
(PAHs) present in tobacco smoke. Objective: The aim of this study was to explore
the magnitude of association between SULT1A1 gene Arg213His polymorphism and
oral cancer, and to explore the interaction between such polymorphism and smoking.
Methods: A hospital-based case-control study was carried out in Rio de Janeiro, Brazil,
during 1999–2002. Epidemiological data and biological samples were obtained from
202 oral cancer patients and 196 sex and age-frequency matched controls without
cancer antecedents. Results: No association was observed between Arg213His SULT1A1
polymorphism and oral cancer risk in overall analysis (OR = 1.06, 95% CI = 0.71–1.57).
The magnitude of association between cigarette smoking and oral cancer was higher
in individuals with a SULT1A1∗1 isoform (wild type, genotype Arg/Arg) (OR = 10.19,
95% CI = 3.90–26.61) than in those with at least one SULT1A1∗2 allele (genotypes
Arg/His + His/His) (OR = 4.50, 95% CI = 2.09–9.69). Conclusion: Our results suggest
that Arg213His SULT1A1 polymorphism may modulate the association between smoking
and oral cancer. However, this association needs to be replicated in other studies: due
to modest number of cases and controls, the role of chance in the observed association
cannot be ruled out.
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INTRODUCTION
Oral cancer is a major public health problem worldwide, result-
ing in 263,020 new cases (3.8 cases/100,000) and 127,654 deaths
(1.9/100,000) per year, with the highest incidence and mortality
rates occurring in developing countries (Ferlay et al., 2010). In
Brazil, according to 2012 estimates, oral cavity cancer will result
in 9990 new cases in males (10 cases per 100,000 men) and 4180
in females (4/100,000 women). However, a marked regional vari-
ation is expected, with incidence rates ranging from 3/100,000
men (2/100,000 women) in the North region to 15/100,000 men
(6/100,000 women) in the Southeast (INCA, 2011).
Tobacco and alcohol consumption are described as the major
environmental risk factors to oral cancer (Anantharaman et al.,
2011; Lubin et al., 2011). Other environmental factors are diet,
pollution (Johnson et al., 2011), oral hygiene (Guha et al., 2007),
and certain virus strains, such as human papillomavirus (HPV)
(Lambert et al., 2011). Regarding genetic risk factors, some
authors have described an association between xenobiotic metab-
olizing enzymes polymorphisms and the development of oral
cancer (Jefferies et al., 1999; Tripathy and Roy, 2006). However,
the basis of this genetic susceptibility is not well understood (Ram
et al., 2011).
The sulfotransferases (SULTs) are phase II detoxification
enzymes involved in the biotransformation of a wide variety of
xenobiotics and endogenous steroid (Nowell and Falany, 2006).
The SULT1A1 isoform is involved in toxic substances inacti-
vation, but it can also bioactive pro-carcinogens such as hete-
rocyclic amines (HCAs) and polycyclic aromatic hydrocarbons
(PAHs) (Bardakci et al., 2008; Koike et al., 2008), both present
in tobacco smoke (International Agency for Research on Cancer:
Tobacco smoke, 2004). SULT1A1 is a polymorphic gene, and
its Arg213His most studied polymorphism results from G to A
nucleotide replacement at exon 7, generating SULT1A1*2 iso-
form (Nagar et al., 2006). The protein derived from SULT1A1*2
(213His variant allele), comparatively to that produced by the wild
type (SULT1A1*1), has a twice lower catalytic activity and more
reduced thermal stability (Koike et al., 2008).
SULT1A1*2 isoform is associated with increased risks of lung
(Pachouri et al., 2006; Liao et al., 2012), stomach cancer (Liang
et al., 2004; Boccia et al., 2005), urothelial cancer (Roupret et al.,
2007), and breast cancer (Lee et al., 2012). However, others stud-
ies reported that SULT1A1*2 isoform could confer not statistically
significant reduced risks to bladder cancer (Hung et al., 2004) and
colorectal cancer (Nowell et al., 2002), as well as a statistically
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significant lung cancer risk reduction in heterozygous individuals
(Ihsan et al., 2011).
With regard to oral cancer, SULT1A1*2 isoform has only been
studied in Taiwan. No association between Arg213His SULT1A1
polymorphisms and oral cancer was observed in that study, but
oral cancer risk in betel quid chewers and smokers seemed to
be lower in individuals with a SULT1A1*2 isoform compared to
those with the wild type genotype (Chung et al., 2009).
The aim of this study was to investigate the association
between Arg213His SULT1A1 gene polymorphism and oral can-
cer, and to explore any interaction between this polymorphism
and smoking with regard to oral cancer risk.
METHODS
This investigation is part of a multicentric hospital-based case-
control study carried out in Brazil, Argentina, and Cuba aiming
to explore the association between several environmental and
genetic risk factors with oral, larynx, and esophageal cancers
(Guha et al., 2007). The city of Rio de Janeiro was one of the
places wherein the study was performed during 1999–2002, and
as previously described (Marques et al., 2006), cases were 202
patients between 15 and 79-year-old with an histopathologi-
cal confirmed diagnosis of oral cavity squamous cell carcinoma
without previous treatment. Cases were diagnosed in Rio de
Janeiro at the public and free care coverage Brazilian National
Cancer Institute (INCA). Controls (196 patients) were gen-
der and age-frequency matched to cases, being enrolled among
hospitalized patients with no-neoplastic diseases (alcohol- or
tobacco-related illnesses excluded) in two public general hos-
pitals, the Institute of Trauma—Orthopaedics (INTO) and the
Souza Aguiar Municipality General Hospital, both offering free
and universal care in the same city. Hospitalization causes distri-
bution among controls were: injury, poisoning, and certain other
consequences of external causes 28.5%; digestive system diseases,
19.4%; genitourinary system diseases, 17.4%; musculoskeletal
system and connective tissue diseases, 12.8%; respiratory system
diseases, 8.7%; infectious and parasitic diseases, 6.1%; skin and
subcutaneous tissue diseases, 2.6%; and 0.5%, others.
Therefore, control group included a variety of ill individuals
enrolled in general hospitals, all of them presenting illnesses unre-
lated to smoking and alcohol intake in their natural history (i.e.,
emphysema, alcoholic cirrhosis, and others).
All participants were residents in the Metropolitan Region of
Rio de Janeiro. Trained interviewers conducted in-person inter-
views to elicit information on demographic background, tobacco,
and alcohol consumption and other lifestyle habits. Participating
rate was 95% for cases and 86% for controls.
Peripheral blood samples collected in EDTA Vacutainer tubes
were used for genomic DNA extraction following a standard
protocol (Lahiri and Nurnberger, 1991). All proceedings were
approved by the Ethics Research Committees of all involved
institutions.
Genetic polymorphisms were assessed by previously described
PCR-RFLP protocols (Coughtrie et al., 1999), with minor modi-
fications. In brief, the amplification of target DNA was achieved
by PCR optimized conditions as follows: a final reaction vol-
ume of 25µL was composed of 100–200 ng of DNA, 0.2mM of
each dTNP, 4mM of MgCl2, 0.75U of Platinum Taq DNA poly-
merase (Invitrogen), 1× PCR buffer (Invitrogen), and 10 pmol
of each primer (forward 5′gttggctctgcagggtttctagga3′ and reverse
5′cccaaacccccgtgctggccagcaccc3′). The reaction conditions used
were: a pre-denaturation at 94◦C for 5min followed by 50
cycles with three steps each (94◦C for 30 s, 68◦C for 30 s, and
72◦C for 45 s), and a cycle of 7min at 72◦C. Negative con-
trols were included in every run, and the success of amplifi-
cation was confirmed in agarose 1.5% gels, stained with Gel
Red (Biotium), and visualized under ultraviolet (UV) light.
Endonuclease digestions were performed as follows: a final reac-
tion volume of 20µL composed of 5µL of PCR products, 5U
of HaeII enzyme (BioLabs), and 1× reactin buffer (BioLabs),
using overnight 37◦C incubation conditions. Determination of
genotypes was performed in agarose 3% gels, visualized under
UV light.
Goodness-of-fit of genotype distribution to Hardy–Weinberg
equilibrium was ascertained for controls. Unconditional
logistic regression models were used to calculate unad-
justed and adjusted odds ratios (OR) and 95% confidence
intervals (95% CI) for the association between SULT1A1
polymorphism and oral cancer and to explore any inter-
action between this polymorphism and environmental risk
factors. All statistical analyses were done using STATA 10.0
software.
RESULTS
The distribution of oral cancer cases and controls according
to sex, age, skin color, smoking, alcohol consumption, and
Arg213His SULT1A1 genotype are presented at Table 1. About
82.7% of cases and 76.5% of controls were male. Mean age was
55.9 years (±9.9) among cases and 55.1 years (±11.7) among
controls. Regarding skin color, whites accounted for 41.6% of
cases and 53.6% of controls (p = 0.02). Smoking antecedents
were more frequent among oral cancer cases than controls:
among the former, 76.7% were smokers and 14.4% ex-smokers
(respectively, 41.3 and 28.1% among controls, p < 0.01). Alcohol
intake antecedents were reported by 67.3% of cases and 51.0%
of controls (p < 0.01). Data analysis did not show an association
between the presence of at least one SULT1A1*2 allele (geno-
types Arg/His + His/His) and oral cancer (OR = 1.06, 95% CI
0.71–1.57). The OR adjustment for selected confounders (smok-
ing, skin color, age, and sex) revealed similar results (OR = 1.07,
95% CI = 0.69–1.65).
The association between smoking and oral cancer according to
Arg213His SULT1A1 gene polymorphisms is presented at Table 2.
Among subjects with an Arg/Arg genotype, an estimated 10-
folds higher risk of developing oral cancer was observed among
smokers (OR = 10.2, 95% CI = 3.90–26.61) comparatively to no-
smokers. Among former smokers, the estimated risk was OR =
2.98 (95% CI = 1.01–8.78). Among individuals who had at least
one SULT1A1*2 allele (genotypes Arg/His and His/His), the risk
of oral cancer associated with smoking revealed an OR = 4.50
(95% CI = 2.09–9.69) for smokers, and OR = 1.17 (95% CI =
0.46–2.95) for former smokers. When adjusted by age, alcohol
consumption, skin color, and sex, such heterogeneity between
genotype groups became even higher (Table 2).
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Table 1 | Distribution of oral cancer cases and controls according to sex, age, skin color, smoking, alcohol intake, and Arg213His SULT1A1
genotype, Rio de Janeiro, Brazil, 1999–2002.
Variables Controls N (%) Cases N (%) OR (95% Cl)
Sex Female 46 (23.47) 35 (17.33) 1.00
Male 150 (76.53) 167 (82.67) 1.46 (0.89–2.39)
Age (year) 23–40 21 (10.71) 9 (4.46) 1.00
41–50 50 (25.51) 54 (26.73) 2.52 (1.05–6.02)
51–60 49 (25.00) 72 (35.64) 3.43 (1.45–8.11)
61–79 76 (38.78) 67 (33.17) 2.06 (0.88–4.80)
Skin color White 105 (53.57) 84 (41.58) 1.00
Non-white 91 (46.43) 118 (58.42) 1.62 (1.09–2.41)
Smoking Never smoker 60 (30.61) 18 (8.91) 1.00
Current smoker 81 (41.33) 155 (76.73) 6.38 (3.53–11.52)
Former smoker 55 (28.06) 29 (14.36) 1.76 (0.88–3.51)
Alcohol intake No 53 (27.04) 13 (6.44) 1.00
Current 100 (51.02) 136 (67.33) 5.54 (2.87–10.72)
Former 43 (21.94) 53 (26.24) 5.02 (2.43–10.40)
SULT1A1 Arg/Arg 94 (47.96) 94 (46.53) 1.00
Arg/His 82 (41.84) 89 (44.06) 1.08 (0.72–1.64)
His/His 20 (10.20) 19 (9.41) 0.95 (0.48–1.89)
Arg/His +
His/His 102 (52.04) 108 (53.47) 1.06 (0.71–1.57)*
*Adjusted for alcohol consumption, smoking, skin color, age, and sex.
Table 2 | Association between smoking and oral cancer according to
Arg213His SULT1A1 polymorphism, oral cancer cases and controls,
Rio de Janeiro, Brazil, 1999–2002.
Subject Genotype OR (95% CI)
Arg/Arg Arg/His + His/His
Never smoker 1.00 1.00
Ever smoker 7.22 (2.84–18.33) 3.18 (1.52–6.65)
Current Smoker 10.19 (3.90–26.61) 4.50 (2.09–9.69)
Ex-smoker 2.98 (1.01–8.78) 1.17 (0.46–2.95)
ORinteraction, 0.44; p, 0.176.
DISCUSSION
SULT1A1 is a phase II enzyme involved in the metabolism of a
wide variety of xenobiotics and pro-carcinogens bioactivation,
such as PAHs as benzopyrene, which are present in cigarette
smoke (Bardakci et al., 2008).
Several epidemiological studies have consistently shown
tobacco smoking as a major oral cancer risk factor (Garrote et al.,
2001; Lubin et al., 2011). Moreover, a marked oral cancer risk
reduction has been observed after quitting smoking, thus high-
lighting the role carcinogenicity of tobacco smoke to oral cavity
(Castellsagué et al., 2004).
Genetic polymorphisms participating in cigarette compounds
metabolism could affect individual cancer susceptibility by
altering the enzymatic expression or function, which would result
in increased or decreased carcinogens activation. The reactive
intermediate metabolites formed during smoke compounds
metabolism, if not eliminated, can eventually form covalent
reactions (adducts) with DNA, RNA, or proteins. Therefore,
extensive DNA damage may occur, increasing cancer risk (Miller
et al., 2001).
Thus, although tobacco carcinogens can promote a variety of
genetic alterations alone, there is evidence of the involvement of
xenobiotics metabolism genes in the process of transformation
of benign oral lesions into oral carcinomas (Lichtenstein et al.,
2000).
Since SULT1A1 is involved in bioactivation of tobacco smoke
pro-carcinogens and smoking is a major oral cancer risk fac-
tor, Arg213His SULT1A1 polymorphism can hypothetically be
associated with oral carcinogenesis in smokers. In our study,
the magnitude of association between cigarette smoking and
oral cancer was higher in individuals with a SULT1A1*1 iso-
form (wild type, genotype Arg/Arg) (OR = 10.19, 95% CI =
3.90–26.61) than in individuals with at least one SULT1A1*2
allele (genotypes Arg/His + His/His) (OR = 4.50 95% CI =
2.09–9.69), (Table 2, OR interaction p > 0.05). These results sug-
gest that the low enzyme activity variant SULT1A1*2 (213His)
(Koike et al., 2008) may lead to a decreased smoking procarcino-
gens (such as PAHs) bioactivation, thereby reducing the risk of
smoking-related cancers. However, considering the small stud-
ied sample size, the occurrence of chance as an explanatory
reason for this association cannot be ruled out. Additionally,
it could also result from other unanalyzed SULT1A1 poly-
morphisms, or other involved genes in cigarette smoke pro-
carcinogens metabolism. In a small sample size case-control
study, Chung et al. (2009) explored the association between
SUTT1A1 polymorphisms and oral squamous cell carcinoma
(OSCC) susceptibility in male Taiwanese. They also reported
that the presence of Arg213His SULT1A1 polymorphisms was not
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associated with the risk of developing oral cancer (OR = 1.04,
95% CI = 0.19–5.12, when no other SULT1A1 SNP was present).
However, the risk of developing oral cancer in betel quid chewers
and smokers seemed to be lower in SULT1A1*2 isoform patients
comparatively to those with a wild type (OR = 0.58, 95% CI =
0.15–2.28).
The association between Arg213His SULT1A1 polymorphism
and other cancer types has been mixed (Wang et al., 2003).
SULT1A1*2 (213His) allele has been associated with an increased
risk of prostate cancer (OR = 1.60, 95% CI = 0.46–5.62)
(Nowell et al., 2004), stomach cancer (OR = 3.32; 95% CI =
1.17–9.45) (Liang et al., 2004; Boccia et al., 2005), urothelial can-
cer (OR = 2.18, 95% CI = 1.28–3.69) (Roupret et al., 2007),
and breast cancer (OR = 1.12, 95% CI = 1.02–1.24). On the
other hand, a statistically non-significant reduced risks of blad-
der cancer (OR = 0.67, 95% CI = 0.45–1.03) (Hung et al.,
2004) and colorectal cancer (OR = 0.6, 95% CI = 0.3–1.1)
(Nowell et al., 2002) have been reported. With regard to lung
cancer, Pachouri et al. (2006) reported an increased risk of
lung cancer associated with His/His (SULT1A1*2 isoform) geno-
type (OR = 1.40, 95% CI = 0.48–4.06), which was higher among
smokers (OR = 3.9, 95%CI = 1.99–7.81). In contrast, Ihsan et al.
(2011) found an inverse association between SULT1A1 Arg213His
heterozygous genotype (Arg/His) and lung cancer (OR = 0.51,
95% CI = 0.33–0.78).
Results of this study suggest that Arg213His SULT1A1
polymorphism may modulate susceptibility to oral cancer in
smokers. However, as this study had a modest sample size,
the role of chance cannot be excluded. Another limitation of
this study was that we investigated a single polymorphism
with limited data on smoking. Therefore, these results need to
be replicated in further studies. Due to heterogeneous results
on the role of Arg213His SULT1A1 polymorphism in the acti-
vation of smoke procarcinogens and the consequent suscep-
tibility to various cancers, GWAS exploring multiple genes
involved in the metabolism of tobacco smoke compounds are
needed to obtain more comprehensive evidence of possible
interactions between these genes and smoking with regard to
cancer risk.
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